HOME >> MEDICINE >> NEWS
NIAID scientists unveil mechanism behind resistance to severe malaria

Scientists have discovered why people with a specific type of hemoglobin--the oxygen-carrying molecule that gives red blood cells their color--are less prone to severe malaria. In a series of experiments, the researchers determined how hemoglobin type C impairs the ability of malaria parasites to cause disease symptoms.

"This research gives us a new insight into malaria, a major global killer that preys especially on young children and claims a life every 30 seconds," notes Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, where the research was conducted.

"If we better understand the natural protective mechanisms against malaria, we might be able to mimic that protective effect through vaccines or drugs," says NIAID researcher Thomas E. Wellems, M.D., Ph.D., whose team's findings appear this week in the journal Nature.

Hemoglobin exists in several varieties. Hemoglobin A is the most common, but in parts of West Africa, where malaria is rife, one-fourth of the population has at least one gene for hemoglobin C. Children with at least one hemoglobin C gene are less prone to deadly cerebral malaria, in which parasite-infected red blood cells accumulate in the brain. But how hemoglobin C confers this protection has puzzled scientists until now.

To solve the mystery, Dr. Wellems and his colleagues studied laboratory-infected red blood cells and blood drawn from children with malaria from the African nation of Mali. Genetically, the samples fell into three groups: those with two genes for hemoglobin A (AA); those with two genes for hemoglobin C (CC); or those with one gene for each type of hemoglobin (AC).

The scientists then measured three phenomena that affect how well parasitized red blood cells can be made to stick to one another, to uninfected red blood cells and to blood vessel walls. These phenomena--known respectively as aggl
'"/>

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
22-Jun-2005


Page: 1 2

Related medicine news :

1. NIAID releases MDR/XDR Tuberculosis research agenda
2. NIAID DNA vaccine for H5N1 avian influenza enters human trial
3. NIAID media availability: Examining genetic variability of malaria parasite offers insight
4. NIAID awards $4 million to develop anti-radiation treatments
5. Partnership between NIAID and Sequella yields promising new TB drug for clinical testing
6. NIAID announces leadership for newly restructured HIV/AIDS clinical trials networks
7. NIAID study finds higher dose of flu vaccine improves immune response in the elderly
8. NIAID media availability: New study describes key protein from highly pathogenic H5N1 avian flu virus and how it might mutate
9. NIAID media availability: Understanding influenza infection
10. NIAID researchers show how promising TB drug works
11. NIAID awards $47 million to develop medical countermeasures against radiological, nuclear threats

Post Your Comments:
(Date:5/28/2015)... The MIT Sloan Center for Information Systems Research ... of the MIT CISR research team interviewed members of ... case study about Healthcare IQ’s business model within the ... ‘Healthcare IQ: Competing as the “Switzerland” of Health Spend ... hospital financial software provider through its evolution to becoming ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Orem, UT—Dymicron, ... in-human surgeries using their unique Triadyme-C cervical total disc ... surgeon Dr. William D. Smith at the American Institute ... “The patients are responding well to the implantation of ... of AIMIS Spine Center and Chief of Neurosurgery for ...
(Date:5/28/2015)... Aureus Medical Group (web: aureuslocumtenens.com), a national leader ... that it will participate as an exhibitor at the ... be held June 9-14, 2015 in New Orleans, Louisiana. ... and exhibits with products and services. , Representatives ... be available to speak with attendees about its full ...
(Date:5/28/2015)... York, NY (PRWEB) May 28, 2015 Peggy ... elected Chief Delegate to the American Physical Therapy Association House ... by the Delegation at their Delegate Assembly. This will ... House of Delegates serves as coordinator and principle spokesperson for ... Delegates. The Board of Directors or Delegate Assembly may direct ...
(Date:5/27/2015)... and volume loss in the skin have met its ... is excited to introduce a custom menu of non-invasive ... surgical intervention, and without downtime. , “We now use ... that can lift skin using focused ultrasound, and combine ... lifting formula than its predecessor Radiesse, to visibly and ...
Breaking Medicine News(10 mins):Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 2Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 3Health News:Dymicron, Inc., Announces the First Human Implantation of their Triadyme-CTM Cervical Total Disc Replacement Device in Cyprus 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the American Association of Nurse Practitioners’ 2015 National Conference 2Health News:Skin Expert Holly CaSaroll Announces New Cutting Edge Results with RadiessePlus Filler Available at Detroit Skin and Wellness Clinic 2
(Date:5/28/2015)...  Array BioPharma Inc. (NASDAQ: ARRY ) today ... AstraZeneca) at the 2015 American Society of Clinical Oncology ... – June 2, 2015 in Chicago ... a total of 6 pivotal trials, with top-line results ... in NRAS mutant melanoma patients) and SUMIT (selumetinib with ...
(Date:5/28/2015)... , May 28, 2015 The ... North America , Europe ... world (RoW). The global departmental PACS market is expected to ... between 2014 and 2019. Browse through the TOC ... the industry trends and segments, with help of various tables ...
(Date:5/28/2015)... 26, 2015 Research and Markets( http://www.researchandmarkets.com/research/rjpc7h/2015_strategies ... "2015 Strategies in the US Ancillary Hospital Locations ... to their offering. This new 973-page ... of the diagnostic testing markets outside the main ... includes analysis of the market dynamics, size, growth, ...
Breaking Medicine Technology:Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting 2Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting 3Departmental PACS Market is Expected to Reach $3,807.4 Billion by 2019, at a CAGR of 10.0% From 2014 to 2019 2Departmental PACS Market is Expected to Reach $3,807.4 Billion by 2019, at a CAGR of 10.0% From 2014 to 2019 3Strategies in the US Ancillary Hospital Locations (ERs, ORs, ICUs) Diagnostic Testing Market 2015-2020 2
Cached News: